Gabriele Robers
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Introduction: The objective of this study is to compare the 5 year overall survival of patients with stage I–III colon cancer treated by laparoscopic colectomy versus open colectomy. Methods: Using Mecklenburg-Western Pomerania Cancer Registry data from 2008 to 2018, we will emulate a phase III, multicenter, open-label, two-parallel-arm hypothetical target trial in adult patients with stage I–III colon cancer who received laparoscopic or open colectomy as an elective treatment. An inverse-probability weighted Royston‒Parmar parametric survival model (RPpsm) will be used to estimate the hazard ratio of laparoscopic versus open surgery after confounding factors are balanced between the two treatment arms. Further to the hazard ratio, we will also compute differences in the absolute risk (at 1, 3, and 5 years) and restricted mean survival time (up to 1, 3, and 5 years). A weighted Kaplan‒Meier curve will be used to compare five-year overall survival in both treatment arms. Various comparator and sensitivity analyses will be performed to check the robustness of the results that will be estimated by the RPpsm main model. Treatment period- and stage-specific results will also be provided. Discussion: This study aims to causally model the effect of laparoscopic versus open colectomy on 5 year overall survival using a target trial emulation approach. As the cancer registry data do not cover BMI, comorbidity, and previous abdominal surgery for non-malignant indications, the potential for residual confounding arising from these factors is a limitation of this study. This will be approached in a quantitative bias analysis using the E-method. The results will substantiate existing evidence on the comparative effectiveness of laparoscopic versus open colectomy in patients with stage I–III colon cancer and may guide clinical decisions as to whether a laparoscopic approach is as safe as an open approach in terms of improving 5-year overall survival in these patient groups.
Year:
2025
Malignant ovarian germ cell tumors (MOGCT) and ovarian sex cord stromal tumors (SCST) are rare ovarian tumors. Since 2013, all German federal states are obliged to record data on diagnosis, pathology, therapy, and clinical course of tumor diseases. We gathered data on MOGCT and SCST from thirteen federal cancer registries and the German Childhood Cancer Registry. Each of the participating registries provided aggregated data on MOGCT and SCST with date of diagnosis between 01.01.2016 and 31.12.2021. 629 MOGCT and 872 SCST were included, age peaks at diagnosis for MOGCT and SCST were between 20 and 24 years and between 55 and 59 years, respectively. Of all MOGCT, 23%, 22%, 13% and 12% were malignant teratoma, dysgerminoma, neuroendocrine tumors and yolk sac tumors, respectively. The large majority (94%) of SCST represented malignant granulosa cell tumors. Most tumors were diagnosed in FIGO stage I (66% of MOGCT and 85% of SCST). Surgery was reported in 58% of patients with MOGCT and in 73% of patients with SCST. Chemotherapy was administered to 26% of MOGCT patients and 8% of SCST patients. This study highlights the great potential of cancer registries as high numbers of patients are recorded, however, data are highly dependent on the reporting institutions.
Year:
2025
Background Employees at the Ihlenberg toxic waste landfill in northern Germany were found to have an increased risk of cancer and cancer-related deaths in previous analyses covering the time period from 1983 to 2008. The present study aimed to quantify cancer risk and all-cause mortality in the employee cohort in 2009 to 2021. Methods In this retrospective cohort study, cancers were identified by linkage with cancer registries, and employee deaths were obtained from population registries. Standardized incidence ratios (SIRs) for cancers and standardized mortality ratios (SMRs) were calculated to quantify cancer and mortality risk in the employee cohort. The effects of employment duration and different latency periods up to 30 years were additionally considered. Results The cohort of 590 employees (432 men, 158 women) who worked at the landfill for at least 3 months between 1983 and 2018 was established from human resource management documentation and followed from January 1, 2009 until December 31, 2021. During this follow-up period, the SIR for all cancers combined was 0.69 (95% confidence interval (CI): 0.47, 0.98) and the SMR for all-cause mortality was 0.51 (95% CI: 0.35, 0.73). Longer employment at the landfill was not associated with increased cancer incidence or mortality. Conclusions Employment at the landfill, expected to reflect occupational exposure to toxic waste, was not associated with increased cancer incidence or mortality in the employee cohort. Preventive measures to reduce exposure and to promote a healthy lifestyle should be maintained at the landfill.
Year:
2024
Year:
2024
Year:
2023
Collaborators (4)
Ulrike Stentzel
research associate
University Medicine Greifswald
Bernd Kasper
-
Kirsi Manz
Wissenschaftliche Mitarbeiterin
University Medicine Greifswald
Peter Hohenberger
Professor of Surgical Oncology and Thoracic Surgery
University of Heidelberg Bioquant
Make your next move.
Prepare your application
Review drafts before you send them.